Denosumab is a monoclonal antibody that inhibits bone resorption and is widely used across oncology and osteoporosis-related conditions. The Patels added, "With the addition of two denosumab ...

The controversial winner of the World’s Strongest Woman competition was stripped of her title Tuesday after organizers claimed the hulking American never told them she was born a man. Jammie Booker ...

Credit: Celltrion. The FDA originally approved Stoboclo and Osenvelt as biosimilars in March 2025. The interchangeability designation allows Stoboclo and Osenvelt to be substituted at the pharmacy for ...

Stoboclo and Osenvelt, biosimilars of Prolia and Xgeva, are approved for various cancer-related bone conditions, offering cost-effective alternatives. FDA approval confirms therapeutic equivalence of ...

Jubbonti ® (denosumab-bbdz) and Wyost ® (denosumab-bbdz), interchangeable biosimilars to Prolia ® (denosumab) and Xgeva ® (denosumab), respectively, are now available from Sandoz. The ...

It looks like Diana Prince is returning to theaters. A new feature film about DC superhero Wonder Woman is “being written right now,” says DC Studios co-chief James Gunn in an interview with EW. The ...

Co-pay support programs are available for eligible patients prescribed Jubbonti and Wyost. Jubbonti (denosumab-bbdz) and Wyost (denosumab-bbdz), interchangeable biosimilars to Prolia (denosumab) and ...

The United Kingdom’s highest court ruled that the legal definition of “woman” excludes trans women, in a case with sweeping consequences for how equality laws are applied. Britain’s Supreme Court ...

EXCLUSIVE: Democratic lawmakers would not provide a definition of a woman when pressed on Capitol Hill, as President Donald Trump prioritizes making clear distinctions between biological sexes during ...

The FDA approval is based on robust clinical evidence, including results from Phase III clinical trials in postmenopausal women with osteoporosis. The U.S. Food and Drug Administration (FDA) has ...

For decades, the anti-abortion movement has aggressively promoted women into visible leadership roles. It's for cynical reasons, namely, to bat off entirely accurate accusations that the movement is ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term competition thanks to a new agreement between Amgen and Celltrion. Late last week, ...